» Articles » PMID: 31896877

Authors' Reply to Commentary on "Gulati P, Chavan BS, Sidana A. Comparative Efficacy of Baclofen and Lorazepam in the Treatment of Alcohol Withdrawal Syndrome"

Overview
Specialty Psychiatry
Date 2020 Jan 4
PMID 31896877
Authors
Affiliations
Soon will be listed here.
References
1.
Liu J, Wang L . Baclofen for alcohol withdrawal. Cochrane Database Syst Rev. 2017; 8:CD008502. PMC: 6483686. DOI: 10.1002/14651858.CD008502.pub5. View

2.
Addolorato G, Caputo F, Capristo E, Janiri L, Bernardi M, Agabio R . Rapid suppression of alcohol withdrawal syndrome by baclofen. Am J Med. 2002; 112(3):226-9. DOI: 10.1016/s0002-9343(01)01088-9. View

3.
Rose A, Jones A . Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis. Addiction. 2018; 113(8):1396-1406. DOI: 10.1111/add.14191. View

4.
Addolorato G, Leggio L, Abenavoli L, Agabio R, Caputo F, Capristo E . Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med. 2006; 119(3):276.e13-8. DOI: 10.1016/j.amjmed.2005.08.042. View

5.
Gulati P, Chavan B, Sidana A . Comparative efficacy of baclofen and lorazepam in the treatment of alcohol withdrawal syndrome. Indian J Psychiatry. 2019; 61(1):60-64. PMC: 6341928. DOI: 10.4103/psychiatry.IndianJPsychiatry_40_17. View